Hypoglycaemia is an important cause of cerebral damage in childhood. While much attention has recently been directed to its detection and treatment in the neonatal period, in later childhood the diagnosis is often delayed. There are many possible causes of hypoglycaemia in childhood, but in only a minority of cases is a precise diagnosis made, the majority being labelled 'idiopathic'. An insulin-secreting islet cell adenoma of the pancreas (insulinoma) is a rare cause of childhood hypoglycaemia; Drash and Schultz (1967) found fewer than 30 cases in their review. The case of a 12-year-old girl with an insulinoma is described in this paper. In an attempt to establish the incidence of the condition in the United Kingdom, the heads of undergraduate and postgraduate Paediatric Departments were asked if any cases of insulinoma had been encountered by them during the previous 10 years. 4 cases were reported to us and brief details of these patients are also presented.
In the adult the incidence of insulinoma is higher and the diagnostic criteria more clearly defined than in childhood. Our experience and that of others (Drash and Schultz, 1967; Floyd et al., 1964) suggests that diagnostic procedures, such as the tolbutamide test, are frequently unhelpful in childhood. The diagnosis and treatment of the condition in childhood is discussed.
Case History Christine H. was first seen in July 1966 at 114 years of age with a 1-month history of attacks during which she stared vacantly or became unsteady on her feet for a few seconds. On the day of admission she had a generalized convulsion which was preceded by giddiness and nausea. No abnormal physical signs were found. Investigations revealed fasting whole blood sugar 54 mg./100 ml., serum calcium 9 5 mg./100 ml., serum phosphorus 4-5 mg./100 ml., serum alkaline phosphatase 32 KA units. Skull x-ray was normal. An EEG was abnormal and suggestive of centrencephalic epilepsy. A diagnosis of idiopathic epilepsy was made and anticonvulsant therapy started. Despite a variety of drugs which included phenytoin, ethosuximide, Received December 13, 1968. sulthiame, and primidone, she continued to have generalized convulsions approximately twice weekly, frequently in the early morning. She attended a junior school where she was noted at times to appear tired and drowsy.
In July 1967, at the age of 124 years, she was again admitted to hospital. On the day before admission she had been unusually drowsy, and the following morning she was completely unrousable. On examination she was in deep coma, responding only to painful stimuli. She was flushed and sweating, pulse 135/min. Blood pressure 110/80 mm. Hg Initial investigations and treatment. The history and physical findings suggested hypoglycaemic coma. Initial investigations gave the following results: blood sugar 28 mg./100 ml., CSF sugar 23 mg./100 ml., CSF protein 40 mg./100 ml. Plasma electrolytes, urea, calcium, and phosphorus were normal, but the plasma alkaline phosphatase was 60 KA units. Serum salicylate 1 4 mg./100 ml., and plasma proteins and transaminases were normal. The skull and chest x-rays were normal, and the skeletal maturation was assessed as 13 years (Greulich and Pyle). An EEG revealed slow activity of high amplitude bilaterally.
The hypoglycaemia was controlled with difficulty; intravenous dextrose 10 g. (as 50% solution) and hydrocortisone 100 mg. were given, after which the blood sugar rose to 66 mg./100 ml. Glucagon 1 mg. was given, and normoglycaemia was maintained with an intravenous infusion of dextrose 10% and hydrocortisone, together with dextrose feeds via an intragastric tube. Restoration of the blood sugar to normal produced no immediate change in her conscious level which improved slowly during the subsequent 2 days. Corticosteroid therapy was discontinued after 4 days. A period of extreme restlessness and aphasia followed and a left hemiparesis was present. During the following 3 weeks her speech improved, though remaining slurred, and she became able to walk with support. group.bmj.com on October 20, 2017 -Published by http://adc.bmj.com/ Downloaded from only 18 mg./100 ml. at 120 minutes. A slightly raised fasting plasma insulin level of 36 1uU/ml. was recorded, but the subsequent insulin response was within normal limits. Despite the absence of tolbutamide-induced hyperinsulinism, the clinical picture, together with increased random and fasting insulin levels, was felt to be sufficiently typical of pancreatic insulinoma to justify an exploratory laparotomy, which was performed by one of us (A.G.) 1 month after admission.
Operative findings and procedure. The laparotomy was performed through a right paramedian incision. A round, dark red tumour, 1 cm. in diameter, was found in the pancreas at the junction of the body and the tail. An accessory spleen was noted.
Partial pancreatectomy and splenectomy were performed, leaving the head of the pancreas and the accessory spleen intact.
Pathology of pancreas (Dr. A. H. Cameron). The tail and body of the pancreas were approximately 13 cm. in length; 3 cm. from the amputated proximal end of the pancreas was a small round tumour 1 1 cm. in diameter. It was situated close to the splenic artery and vein on the upper border of the pancieas and had a well-defined margin. Its cut surface had a moist red colour. Slicing of the pancreas after fixation, at intervals of 0 4 cm., showed no further tumour, but six lymph nodes, the largest measuring 1 * 0 cm. in diameter.
Histology showed normal exocrine tissue of the pancreas, and the islets were of normal size and number. The lymph nodes showed oedema of the sinusoids. The tumour was an islet cell adenoma. There was no investing capsule, and in one area the tumour infiltrated adjacent glandular tissue. It consisted of anastomosing short irregular cords of somewhat polyhedral shape, the cords being separated by a rich network of blood-filled sinusoids. The tumour cells varied a little in appearance, the cytoplasm being unusually pale but eosinophilic in some areas. There was slight to moderate mitotic activity. Gomori's aldehyde fuchsin for ,B-cells was negative, though positive in surrounding islets. Bodian's method for a-cells showed a positive reaction in many of the cells of the tumour as well as in the surrounding normal islets.
The insulin activity of tissue from the tumour was three times that of an equal quantity of tissue from the surrounding normal pancreas.
Post-operative course and further follow-up.
The immediate post-operative course was uneventful. Plasma insulin values fell promptly to normal. Transient hyperglycaemia and glycosuria, without acidosis, occurred and lasted for less than 24 hours. The pancreas continued at first to produce excessive insulin secretion after intravenous tolbutamide and oral glucose, suggesting either compensatory hypertrophy of the remaining islet tissue, or the presence of another insulinoma. Glucose tolerance tests have been performed at intervals, and the results are given in Table II . The glucose response has remained within normal limits but the insulin response, which was initially raised, has progressively returned to normal during a 12-month follow-up period. A tolbutamide test (Fig.) performed 6 months after operation again provoked a pronounced fall in the blood glucose levels, and surprisingly the insulin response was within the abnormal range (136 ptU/ml. at 71 minutes). However, no further episodes of hypoglycaemia have been recorded, and x-rays of the chest and bones have shown no evidence of metastases, so we do not consider that another insulinoma is present.
The hypoglycaemia produced evidence of cerebral damage which was initially severe, but her recovery has been better than was anticipated. Aphasia and left hemiparesis were apparent when she regained consciousness. For several months after pancreatectomy her behaviour was violent and aggressive, necessitating a period of in-patient care in hospital for the mentally subnormal. Treatment with chlorpromazine and anticonvulsants produced an improvement in her social response and she is now cared for at home. Intelligence testing (Wechsler Intelligence Scale for Children) performed 6 months after operation gave a value of 61, and 12 months after it was 67. Apart from slight dysarthria there are now no localizing neurological signs. Her behaviour has improved but she has not yet been able to adjust to ordinary school life.
Discussion
Incidence of insulinoma in childhood. We have reviewed the literature on this subject and found 34 published cases in children aged less than 15 years, not including our own case (Antony, Underwood, and Van Wyk, 1967; Bernheim et al., 1961a; Boley, Lin, and Schiffmann, 1960; Massachusetts General Hospital, 1962; Drash and Schultz, 1967; Garces, Drash, and Kenny, 1968; Geraud et al., 1966; Hartmann et al., 1960; Hurez et al., 1961; MacGillivray, Galloway, and Easton, 1958; McQuarrie, 1954; Rogers, 1960; Salinas et al., 1968; Sauls, 1968; Scholten and van der Vegt, 1960; Thomson and Welch, 1962; Watkins and Traylor, 1963 Wolf, Hare, and Riggs (1933) .
Two of the children had malignant insulinomas (Hurez et al., 1961; Thomson and Welch, 1962 (Garces et al., 1968) .
Biochemical diagnosis. Biochemical confirmation of a suspected insulinoma is difficult but has been made easier by the availability of insulin assays. Hyperinsulinism may be suggested by the presence of Whipple's triad (Whipple, 1944) , i.e. symptoms which characteristically occur in the early morning before breakfast or after physical effort and which can be provoked by fasting, associated with blood sugar levels below 50 mg./ 100 ml., and relieved by the administration of sugar. However, in the younger child the presence of Whipple's triad does not distinguish insulinoma from other causes of hypoglycaemia, such as the idiopathic hypoglycaemia of infancy described by McQuarrie (1954) , and islet hyperplasia.
The characteristic glucose tolerance curve of hyperinsulinism shows a low fasting level, and hypoglycaemia may occur again 3 or 4 hours after the load. The test in our patient was atypical due to corticosteroid therapy and a high glucose intake.
Excessive and prolonged hypoglycaemia after intravenous tolbutamide is a useful diagnostic pointer towards insulinoma in adults, and occurred in our case. However, many investigators (Antony et al., 1967; Cunningham, 1964; Di George and Chiowanich, 1962; Drash and Schultz, 1967; Erlich and Martin, 1967; Schotland, Kaplan, and Grumbach, 1967) have found the test less valuable in childhood. This is because similar results occur in children with hypoglycaemia from other causes, notably McQuarrie's idiopathic type, leucine-sensitivity, and islet cell hyperplasia.
Tolbutamide often produces a dramatic rise in plasma insulin levels when an insulinoma is present. The failure to show this in our patient before operation was disappointing, but others (Cunningham, 1964; Drash and Schultz, 1967; Garces et al., 1968; Marks and Rose, 1965 ) have had similar negative results. It is possible that we missed the peak plasma insulin level as this may occur within 5 minutes of the tolbutamide injection (Maingay et al., 1967) . We consider, therefore, that the tolbutamide test is of limited usefulness in childhood.
Oral leucine (Antony et al., 1967; Di George and Auerbach, 1960; Garces et al., 1968; Marks and Rose, 1965) and intramuscular or intravenous glucagon (Garces et al., 1968; Marks The detection of raised fasting plasma insulin levels is the most useful single diagnostic guide. However, multiple estimations may be required before a raised level is demonstrated (Marks and Rose, 1965) , and in 2 cases raised plasma insulin levels were never found (Drash and Schultz, 1967; Garces et al., 1968) . Grant (1967) found the normal range of fasting plasma insulin in children to vary from undetectable levels to 32 ,U/ml. (mean = 8 ,U/ml.). He showed that there was a progressive rise in fasting insulin levels with increasing age through childhood, but that children aged 11 to 15 years (range 7-32 ,tU/ml., mean 16 ptU/ml.) had significantly higher levels than adults (range 6-20 ,tU/ml. mean 10 ,uU/ml.).
Normal levels measured in the Institute of Child Health, Birmingham, lie within a similar range, with the upper limit of normal for the 11 to 15 years age-group being 25 ,U/ml.
We are unable to explain the high alkaline phosphatase level in our patient. There is no evidence of hyperparathyroidism, the tumour did not produce biliary obstruction, and there has been no evidence of metastases in the liver or bones. The alkaline phosphatase level returned to normal after subtotal pancreatectomy. We have found no reference to this phenomenon in the literature on insulinoma. A possible explanation is that alkaline phosphatase was being produced by the adenoma.
Treatment. When raised fasting plasma insulin levels are detected in an infant or child with resistant spontaneous hypoglycaemia, early surgical exploration should be undertaken. A thorough search should be made for an insulinoma in the pancreas itself and also in the sites where an ectopic pancreatic tumour may be found (Lancet, 1967) , bearing in mind that more than one tumour may be present. A simple excision of the tumour may be sufficient, but subtotal pancreatectomy is the more usual procedure.
A problem arises when no obvious tumour is present. The results of 'blind' pancreatectomy in adults were analysed by Mengoli and Le Quesne (1967) who found a tumour in the excised distal pancreas in only 11 of 47 such cases. (In 24 cases a tumour was found at a subsequent operation performed for persisting symptoms.) The problem in children with hyperinsulinism is influenced by the alternative diagnosis of islet cell hyperplasia, for in these cases subtotal pancreatectomy is indicated if medical treatment has failed (Hamilton et al., 1967; Peters and Stanten, 1965) . Moreover, the operation of subtotal pancreatectomy is technically simpler in children than in adults. Therefore, where hyperinsulinism has been shown in a child with resistant spontaneous hypoglycaemia, we suggest that a subtotal pancreatectomy be done if an insulinoma is not found.
The medical treatment of hypoglycaemia due to islet cell adenoma is ineffective, and the hypoglycaemia tends to become progressively more severe. Frequent carbohydrate feeds, and corticosteroid and ACTH therapy are of only temporary benefit (Boley et al., 1960) . Diazoxide, a hyperglycaemic benzothiadiazine derivative, which inhibits insulin release from the islet cells, has been of use in the management of some adults with insulinomas, particularly to control hypoglycaemia from metastases (Ernesti et al., 1965; Marks, Rose, and Samols, 1965) . Diazoxide was ineffective in the 3 infants described by Garces et al. (1968) and Salinas et al. (1968) . The use of very large doses of diazoxide was successful in controlling the hypoglycaemia in a 10-year-old girl with microadenomatosis of the pancreas as part of the pluriglandular syndrome, but side-effects were troublesome (Lloyd, 1968 ). An antibiotic extracted from Streptomyces acromogenes, Streptozotocin, which damages the ,B-cells of the pancreatic islets in animals and produces diabetes mellitus, controlled the hypoglycaemic symptoms in an adult with a malignant islet cell tumour (Murray-Lyon et al., 1968) . The tumour also secreted gastrin and glucagon and the production of these hormones was diminished by the drug. Further trials of treatment with this new drug are required. We conclude that medical treatment of insulinoma is indicated only to enable an accurate diagnosis to be made, or if immediate operation is contraindicated for some reason.
This contrasts with the more favourable results of diazoxide therapy for leucine sensitivity (Drash and Wolff, 1964; Bower, Rayner, and Stimmler, 1967) , where the hypoglycaemia is due to leucineinduced hyperinsulinism. In this condition the natural history is towards gradual improvement so that medical therapy is justifiable.
Dietary measures and corticosteroid or ACTH treatment will usually control the idiopathic hypoglycaemia of childhood (McQuarrie, 1954) , which also has a tendency to natural recovery.
In small infants, therefore, where diagnosis of the exact cause of hypoglycaemia may be difficult, we suggest that dietary measures, steroid or ACTH, and diazoxide therapy should be given a trial, and early surgical exploration should be made if these fail.
Prognosis. There is no long-term series of follow-up studies of insulinoma treated in childhood. A study of Whipple's 6 patients 25 years after the original treatment gives a depressing picture of the condition in adults (Markowitz, Slanetz, and Frantz, 1961 (Frank, 1935; Wolf et al., 1933) and one was in a neonate (Scholten and van der Vegt, 1960) .
The two children with malignant tumours were both well at 6 months (Hurez et al., 1961) and 6 years (Thomson and Welch, 1962) A 10-year-old girl was admitted to hospital in 1962 in hypoglycaemic coma (blood sugar 60 mg./100 ml.) and responded to intravenous glucose. For 2 years she had been having episodes, usually just before her dinner, of hunger, inability to concentrate, sweating, clumsiness, and drowsiness. Three days before admission she had been unconscious at home for a few hours.
Investigations showed fasting hypoglycaemia associated with raised fasting plasma insulin levels (121, 52, 50 ,U/ml.). There was a prolonged hypoglycaemic response to intravenous tolbutamide (blood glucose 25 mg./100 ml. at 20, 30, 60, 90, and 120 minutes) associated with a high plasma insulin response (maximum 327 ,uU/ml. at 20 minutes). Leucine sensitivity was present. A glucose tolerance test showed a low peak of 65 mg./100 ml. at 30 minutes, followed by a fall to hypoglycaemic levels (20 mg./100 ml.) at 2 hours.
At laparotomy (Mr. E. B. Whittingham) two islet cell tumours were removed from the tail of the pancreas.
Recovery remained complete during 2i years of followup. No hypoglycaemic brain damage occurred.
Case 3 (G. A. Neligan, Newcastle). This 14-year-old boy was first admitted to hospital in Hartlepool by Dr. R. G. Welch in 1963, with a 2-month history of attacks of weakness and incoordination of his legs. For 1 month he had also had attacks of slurred speech, hallucinations, and possibly loss of consciousness. These attacks usually occurred before breakfast and during the midmorning and would be cured by a sweet drink. Hypoglycaemia was diagnosed and he was referred to Newcastle. In hospital there he had several attacks of aggressive, 'drunken' behaviour in which sweating was observed. Investigations included a 24-hour fast, after which the blood sugar was 29 mg./100 ml. Intramuscular glucagon produced an initial rise in blood sugar, followed by hypoglycaemia at 2i hours after the injection.
At laparatomy (Professor A. G. R. Lowdon) a tumour 1 cm. in diameter was found on the posterior surface of the body of the pancreas, after a long search. The tumour, an islet cell adenoma, was removed, and the child made a complete recovery. He was symptomfree when reviewed 6 months after the operation by Dr. Welch, and the fasting blood sugar level was normal.
Case 4 (J. W. Farquhar, Edinburgh). This baby boy presented in 1967 with hypoglycaemic convulsions at the age of 3 days. These occurred frequently for 3 weeks and prednisolone was given. Motor retardation was obvious, and further convulsions occurred with normal blood glucose levels. When the steroid was withdrawn hypoglycaemic incidents recurred.
Investigations included blood glucose levels below 10 mg./100 ml. during convulsions; and a fasting plasma insulin level of 65 tkU/ml. The response to a glucose load was small but not otherwise abnormal. Muscle and liver biopsies were unrevealing and the pancreas was macroscopically normal at laparotomy. A distal pancreatectomy was done and an islet cell adenoma approximately 1 x 0 5 x 0 4 cm. was found on examination of the specimen.
Hypoglycaemia did not recur after operation, but phenobarbitone was required to control convulsions which were assumed to be due to the previous hypoglycaemic brain damage.
